DDS is collecting data about factors impacting the DSP workforce to help address workforce stability. Agencies employing DSP’s should receive an email invitation in May 2022 to participate in the data collection

The 2nd RCFE Provider Stakeholder meeting took place last Apr. 25 where licensed RCFE providers in attendance were given the opportunity to discuss statewide topics and concerns with CDSS CCLD.

In the Spring of 2022, DDS will conduct a survey to collect quantitative information about factors impacting Direct Support Professionals (DSPs) during the 2021 calendar year. All agencies that employ DSPs will be requested to participate in the survey.

The Community Care Licensing Division (CCLD) of the California Department of Social Services (CDSS) hosted the 1st RCFE Provider Stakeholder meeting last Jan. 31. This is a quarterly meeting participated by licensed RCFE providers in California and serves as a platform to discuss statewide topics and concerns.

The California Department of Social Services (CDSS), Adult and Senior Care Program (ASCP) has made some changes to optimize administration services. The CCLD programs are now more evenly distributed so that similar work can be done without duplicating efforts, improving resident safety in adult care facilities across the state.

The Administrator Certification Section (ACS) of the California Department of Social Services through “The WIRE”, an electronic communication from ACS has announced that it will distribute Notice of Incomplete Application(s) to Certified Administrators beginning next month, February 1.

California Department of Social Services through its Community Care Licensing Division (CCLD) has released an updated Emergency and Disaster Plan form for Adult Care Facilities.

The Good Samaritan laws that govern the use of EpiPen auto-injectors which are prescribed by licensed health care professionals in Civil Code section 1714.23(b)(1) and Health and Safety Code (HSC) section 1797.197a., allow a licensee of an adult or senior care facility to use a lawfully prescribed EpiPen auto-injector on a client or resident who is suffering or reasonably believed to be suffering from anaphylaxis.

This call will focus on (1) updates on the Omicron variant and monoclonal antibodies (2) how to work through common challenges with visitors (3) how to care for persons in care diagnosed with COVID-19 (4) and addressing the balance of wellbeing and safety for persons in care.